Unknown

Dataset Information

0

Carbon-Ion Beam Irradiation Alone or in Combination with Zoledronic acid Effectively Kills Osteosarcoma Cells.


ABSTRACT: Osteosarcoma (OSA) is the most common malignant bone tumor in children and adolescents. The overall five-year survival rate for all bone cancers is below 70%; however, when the cancer has spread beyond the bone, it is about 15-30%. Herein, we evaluated the effects of carbon-ion beam irradiation alone or in combination with zoledronic acid (ZOL) on OSA cells. Carbon-ion beam irradiation in combination with ZOL significantly inhibited OSA cell proliferation by arresting cell cycle progression and initiating KHOS and U2OS cell apoptosis, compared to treatments with carbon-ion beam irradiation, X-ray irradiation, and ZOL alone. Moreover, we observed that this combination greatly inhibited OSA cell motility and invasion, accompanied by the suppression of the Pi3K/Akt and MAPK signaling pathways, which are related to cell proliferation and survival, compared to individual treatments with carbon-ion beam or X-ray irradiation, or ZOL. Furthermore, ZOL treatment upregulated microRNA (miR)-29b expression; the combination with a miR-29b mimic further decreased OSA cell viability via activation of the caspase 3 pathway. Thus, ZOL-mediated enhancement of carbon-ion beam radiosensitivity may occur via miR-29b upregulation; co-treatment with the miR-29b mimic further decreased OSA cell survival. These findings suggest that the carbon-ion beam irradiation in combination with ZOL has high potential to increase OSA cell death.

SUBMITTER: Kim EH 

PROVIDER: S-EPMC7140041 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Carbon-Ion Beam Irradiation Alone or in Combination with Zoledronic acid Effectively Kills Osteosarcoma Cells.

Kim Eun Ho EH   Kim Mi-Sook MS   Takahashi Akihisa A   Suzuki Masao M   Vares Guillaume G   Uzawa Akiko A   Fujimori Akira A   Ohno Tatsuya T   Sai Sei S  

Cancers 20200316 3


Osteosarcoma (OSA) is the most common malignant bone tumor in children and adolescents. The overall five-year survival rate for all bone cancers is below 70%; however, when the cancer has spread beyond the bone, it is about 15-30%. Herein, we evaluated the effects of carbon-ion beam irradiation alone or in combination with zoledronic acid (ZOL) on OSA cells. Carbon-ion beam irradiation in combination with ZOL significantly inhibited OSA cell proliferation by arresting cell cycle progression and  ...[more]

Similar Datasets

| S-EPMC4274003 | biostudies-literature
| S-EPMC5665000 | biostudies-literature
| S-EPMC7775398 | biostudies-literature
2016-07-01 | GSE78998 | GEO
2016-07-01 | GSE78994 | GEO
2016-07-01 | GSE78997 | GEO
2016-07-01 | E-GEOD-78998 | biostudies-arrayexpress
2008-06-09 | GSE11629 | GEO
| S-EPMC8564971 | biostudies-literature
2008-09-02 | GSE8993 | GEO